| Metric | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥3,662.2B | ¥3,394.7B | +7.9% |
| Operating Income | ¥171.1B | ¥164.3B | +4.1% |
| Ordinary Income | ¥180.4B | ¥169.4B | +6.4% |
| Net Income | ¥122.0B | ¥111.8B | +9.1% |
| ROE | 8.2% | 7.8% | - |
For the cumulative period of Q3 2026 FY, Revenue was ¥3,662.2B (YoY +¥267.5B +7.9%), Operating Income was ¥171.1B (YoY +¥6.8B +4.1%), Ordinary Income was ¥180.4B (YoY +¥11.0B +6.4%), and Net Income was ¥122.0B (YoY +¥10.2B +9.1%), achieving year-over-year increases at all profit levels. While revenue maintained steady growth, Operating Margin declined to 4.7% from 4.8% a year earlier (down 0.1pt), indicating that profitability improvements have not kept pace with top-line expansion. Gross margin declined to 25.5% from 26.0% (down 0.5pt), but SG&A ratio improved to 20.8% from 21.1% (improved 0.3pt), with cost efficiency partially offsetting the gross margin drop. At the ordinary income level, non-operating income doubled to ¥13.2B (prior ¥6.6B), supported by increases in interest income and real estate rental income, resulting in an improvement in Ordinary Margin to 4.9% (up 0.1pt). Net margin was maintained at 3.3% year-on-year, and the effective tax rate stood at 32.3%, a normal level.
Revenue rose to ¥3,662.2B (YoY +7.9%). Segment information is not disclosed, citing that the proportion of the Drugstore Business is high and disclosure is of limited materiality, but revenue growth is presumed driven by both existing-store growth and new store openings. Gross margin fell to 25.5% from 26.0% a year earlier, and gross profit was ¥934.2B (prior ¥880.9B), up only +6.0%. Drivers of gross margin decline likely include price competition pressure, product-mix shifts such as dispensing and OTC pharmaceuticals, and higher logistics and procurement costs. SG&A increased to ¥763.1B (prior ¥716.6B, +6.5%), but the SG&A ratio improved to 20.8% from 21.1% (improved 0.3pt), reflecting absorption of fixed costs due to revenue expansion. Major expense items showed salaries and allowances at ¥312.1B (prior ¥287.8B, +8.4%), highlighting notable labor cost growth, while rent was ¥142.8B (prior ¥136.5B, +4.6%) and remained low at 3.9% of sales, indicating strong store efficiency. Depreciation and amortization (recorded in SG&A) was ¥43.5B (prior ¥39.2B), and goodwill amortization was ¥0.8B (prior ¥0.6B), both minor. Operating Income rose to ¥171.1B (+4.1%), a slower increase than revenue growth of +7.9%. Non-operating income doubled to ¥13.2B (prior ¥6.6B), driven by increases in interest income ¥1.7B (prior ¥1.0B) and real estate rental income ¥6.96B (prior ¥2.96B). Non-operating expenses rose to ¥3.9B (prior ¥1.5B), but interest expense was only ¥0.1B, indicating nearly no interest-bearing debt burden. Ordinary Income increased to ¥180.4B (+6.4%), outpacing operating-level growth. Extraordinary items were minor: extraordinary gains ¥0.8B (subsidies ¥0.8B) and extraordinary losses ¥0.9B (loss on disposal of fixed assets ¥0.2B, impairment losses ¥0.8B). Profit before tax was ¥180.3B (+9.3%). After deducting income taxes of ¥58.2B, Net Income was ¥122.0B (+9.1%), achieving a higher growth rate than operating income. In conclusion, this is a revenue- and profit-expansion pattern, but declining gross margin limited operating leverage, and growth in non-operating income supplemented profit growth.
Operating cash flow benefited from inventory decreasing ¥7.2B from ¥456.6B to ¥449.4B, indicating inventory normalization. Accounts payable decreased ¥2.7B from ¥597.6B to ¥594.9B, so cash generation from supplier terms was limited. Accounts receivable increased ¥4.0B from ¥175.1B to ¥179.1B, modestly pressuring working capital due to revenue growth. Cash and deposits decreased ¥66.7B from ¥377.5B to ¥310.8B, suggesting allocation toward fixed asset investment and new M&A. Tangible fixed assets increased ¥115.0B from ¥863.4B to ¥978.4B, reflecting continued active investment in new store openings and renovations. Intangible fixed assets rose ¥5.5B from ¥9.4B to ¥14.9B, indicating system investments and customer-related asset accumulation. Goodwill increased ¥6.3B from ¥2.9B to ¥9.2B, implying small-scale M&A activity, but scale is minimal at 0.6% of net assets and financial impact is minor. Rent burden is suppressed at 3.9% of sales, and fixed-cost cash outflows are well controlled. With negligible extraordinary items, recurring cash generation appears to be stably linked to Operating Income growth.
Of Ordinary Income ¥180.4B, Operating Income ¥171.1B accounts for 94.8%, indicating high dependency on core operations. Non-operating income ¥13.2B (0.36% of sales) comprised interest income ¥1.7B, real estate rental income ¥6.96B, and other ¥4.5B; rental income doubled from ¥2.96B to ¥6.96B, suggesting effective utilization of idle assets and expanded tenant income from stores. Non-operating expenses ¥3.9B comprised interest expense ¥0.1B, rental expenses ¥3.2B, and other ¥0.6B, and correspond to costs related to rental income, yielding a net contribution of approximately ¥3.8B. Extraordinary items were negligible: extraordinary gains ¥0.8B (subsidies ¥0.8B) and extraordinary losses ¥0.9B (loss on disposal of fixed assets ¥0.2B, impairment losses ¥0.8B), meaning the bulk of Net Income ¥122.0B is generated from recurring operations. Comprehensive income was ¥121.2B, nearly identical to Net Income ¥122.0B, with valuation difference on available-for-sale securities ¥0.1B and actuarial gains/losses -¥0.9B; adjustments from other comprehensive income were small at -¥0.9B, indicating limited accounting distortions. The effective tax rate was 32.3% (Income Taxes ¥58.2B ÷ Profit before tax ¥180.3B), a normal level with no notable tax anomalies. From an accrual standpoint, Operating Income ¥171.1B saw only minor working capital fluctuations, suggesting good cash conversion of earnings. Overall, there are few transitory factors or accounting distortions, and the company has a core, sustainable earnings structure centered on its main business.
Full Year / FY forecasts are maintained at Revenue ¥4,915.0B (YoY +7.5%), Operating Income ¥241.0B (YoY +6.5%), Ordinary Income ¥249.0B (YoY +6.3%), and Net Income ¥163.0B. Progress rates at the cumulative Q3 point are: Revenue 74.5% (¥3,662.2B ÷ ¥4,915.0B), Operating Income 71.0% (¥171.1B ÷ ¥241.0B), Ordinary Income 72.5% (¥180.4B ÷ ¥249.0B), and Net Income 74.9% (¥122.0B ÷ ¥163.0B). Revenue and Net Income have roughly reached the standard 75% progress, but Operating Income lags standard by -4.0pt and Ordinary Income lags by -2.5pt. The operating income shortfall is likely due to gross margin decline (Q3 cumulative 25.5%, with an assumption of improvement for the full year) and the front-loading of SG&A (notably personnel and promotion expenses). Q4 is expected to benefit from seasonal demand such as hay fever season; if unit prices, product mix, and cost control improve, achieving full-year targets is feasible. Forecast EPS is ¥252.31, and forecast dividend is ¥45.0 (including interim dividend already paid ¥34.0), with a Full Year payout ratio of about 17.8%, maintaining a conservative stance.
An interim dividend of ¥45.0 was paid at the end of Q2 (the full-year dividend forecast is ¥45.0). Based on Full Year Net Income forecast ¥163.0B and shares outstanding (excluding treasury stock) 64.6 million shares, forecast EPS is ¥252.31 and payout ratio is about 17.8% (¥45.0 ÷ ¥252.31), staying low. On a Q3 cumulative Net Income base of ¥122.0B, the implied payout ratio is approximately 24.6% (interim dividend ¥45.0 × 64.6 million shares ÷ ¥122.0B), reflecting a conservative return policy. No share buyback has been disclosed; shareholder returns are limited to dividends. With cash and deposits ¥310.8B and net cash ¥294.2B, ample liquidity and negligible interest-bearing debt support dividend sustainability. Given the Net Income growth trend (+9.1%) and stable cash generation, there is sufficient scope for medium-term dividend increases, but management appears to prioritize growth investments (new store openings, system investment, etc.) at this time.
This report is an earnings analysis document automatically generated by AI analyzing XBRL financial statement data. It is not a recommendation to invest in any particular security. Industry benchmarks are reference information compiled by the Company based on public financial statement data. Investment decisions are your responsibility; please consult a professional as necessary before making any investment decision.